Macquarie Group’s Applied Therapeutics APLT Stock Holding History

Macquarie Group’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-209,341	Closed	-$1.78M	–	1665
2024 Q3	$1.78M	Sell	209,341 -19,812	-9%	-$117K	﹤0.01%	1269
2024 Q2	$1.07M	Buy	229,153 +222,417	+3,302%	+$1.05M	﹤0.01%	1366
2024 Q1	$46	Buy	+6,736	New	+$30.2K	﹤0.01%	1656
2022 Q2	–	Sell	-393	Closed	-$1	–	2572
2022 Q1	$1	Hold	393	–	–	﹤0.01%	2615
2021 Q4	$4K	Hold	393	–	–	﹤0.01%	2577
2021 Q3	$7K	Hold	393	–	–	﹤0.01%	2571
2021 Q2	$8K	Hold	393	–	–	﹤0.01%	2487
2021 Q1	$7K	Sell	393 -121	-24%	-$2.61K	﹤0.01%	2419
2020 Q4	$11K	Hold	514	–	–	﹤0.01%	2295
2020 Q3	$11K	Hold	514	–	–	﹤0.01%	2266
2020 Q2	$19K	Buy	+514	New	+$21.5K	﹤0.01%	2175

Other funds holding APLT

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Macquarie Group's APLT Position: Q4 2024 in Review

Macquarie Group sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 209,341 shares — an estimated $1.78M sold.

Macquarie Group first reported a position in APLT in Q2 2020 and held it in 11 quarters. The position peaked at $1.78M in Q3 2024. 118 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

Macquarie Group reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
Macquarie Group sold 209,341 Applied Therapeutics shares in Q4 2024, an estimated $1.78M.
Macquarie Group first reported a position in Applied Therapeutics in Q2 2020 and held it in 11 quarters.
Macquarie Group's Applied Therapeutics position peaked at $1.78M in Q3 2024.
118 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Macquarie Group's 13F filing for Q4 2024, filed 14 Feb 2025.